P3 Health Partners (PIII) Cost of Revenue (2021 - 2025)

P3 Health Partners has reported Cost of Revenue for 5 years, with the latest figure at $335000.0 in Q4 2025.

• For the quarter ending Q4 2025, Cost of Revenue fell 99.98% year-over-year to $335000.0; the trailing twelve-month figure through Dec 2025 stood at $724.0 million (down 62.37% YoY), and the FY2025 full-year result was $918000.0, down 99.94% from the prior year.
• Cost of Revenue for Q4 2025 stood at $335000.0, up from $251000.0 in the prior quarter.
• The five-year high for Cost of Revenue was $1.6 billion in Q4 2024, with the low at -$346.4 million in Q4 2021.
• Historically, Cost of Revenue has averaged $256.2 million across 5 years, with a median of $208.1 million in 2021.
• The largest YoY upside for Cost of Revenue was 115441.3% in 2025 against a maximum downside of 99.98% in 2025.
• P3 Health Partners' Cost of Revenue stood at -$346.4 million in 2021, then surged by 404.19% to $1.1 billion in 2022, then plunged by 65.11% to $367.7 million in 2023, then surged by 323.88% to $1.6 billion in 2024, then tumbled by 99.98% to $335000.0 in 2025.
• The last three Cost of Revenue figures came in at $335000.0 (Q4 2025), $251000.0 (Q3 2025), and $351.3 million (Q2 2025), per Business Quant data.